You have 9 free searches left this month | to do more

sirolimus

Sirolimus is a drug used to treat Kidney Transplantation, Graft Versus Host Disease, Leukemia, and other conditions. Sirolimus is being actively studied in 92 studies and prior, has been studied in 165.

Top SponsorsTop SitesTop Investigators
National Institute of Allergy and Infectious Diseases (NIAID)National Institutes of Health Clinical Center, 9000 Rockville PikeBing Han
Wyeth is now a wholly owned subsidiary of PfizerMassachusetts General HospitalCorey S. Cutler, MD, MPH
Fred Hutchinson Cancer CenterFred Hutch/University of Washington Cancer ConsortiumDamiano Rondelli, MD
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Not yet recruiting
  • Aging
  • Sirolimus
  • (no location specified)
2022-03-08
Mar 8, 2022
W
Completed
  • Vascular Anomaly
  • Sirolimus
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
2022-03-12
Mar 12, 2022
M
Recruiting
  • Venous Malformation
  • Lymphatic Malformation
  • Sirolimus
  • Charleston, South Carolina
    Medical University of South Carolina
2022-02-07
Feb 7, 2022
U
Recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +2 more
  • Sirolimus
  • Toronto, Ontario, Canada
    St. Michael's Hospital
2022-02-25
Feb 25, 2022
U
Not yet recruiting
  • Graves Ophthalmopathy
  • Sirolimus
  • Pisa, Italy
    Ospedale Cisanello-Endocrinology II
2022-02-17
Feb 17, 2022
M
Active, not recruiting
  • Ovarian Serous Tumor
  • Recurrent Ovarian Carcinoma
  • Rochester, Minnesota
    Mayo Clinic
2022-03-22
Mar 22, 2022
U
Terminated
  • Kidney Transplant
  • Delayed Graft Function
  • Baltimore, Maryland
    University of Maryland Medical Center
2022-03-29
Mar 29, 2022
B
Completed
  • Pure Red Cell Aplasia
  • Sirolimus
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
2021-07-01
Jul 1, 2021
U
Recruiting
  • Cerebral Aneurysm
  • Microsurgical clipping
  • +2 more
  • Miami, Florida
    University of Miami
2021-10-28
Oct 28, 2021
N
Recruiting
  • Severe Aplastic Anemia
  • Sirolimus
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
U
Recruiting
  • Metastatic Thyroid Cancer
  • Ann Arbor, Michigan
    University of Michigan Cancer Center
2021-12-15
Dec 15, 2021
U
Recruiting
  • Castleman Disease
  • Castleman's Disease, Multicentric
  • Sirolimus
  • Little Rock, Arkansas
  • +1 more
2021-11-17
Nov 17, 2021
W
Recruiting
  • Kaposiform Hemangioendothelioma
  • Kasabach Merritt Phenomenon
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
2021-03-03
Mar 3, 2021
B
Recruiting
  • Pure Red Cell Aplasia, Acquired
  • Sirolimus
  • Cyclosporine A
  • Beijing, China
    Peking Union Medical College Hospital
2021-07-01
Jul 1, 2021
O
Recruiting
  • PTEN Gene Mutation
  • +6 more
  • Sirolimus
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
2021-11-12
Nov 12, 2021
A
Completed
  • Sturge-Weber Syndrome
  • Sirolimus
  • Baltimore, Maryland
  • +1 more
2021-09-30
Sep 30, 2021
U
Not yet recruiting
  • Inclusion Body Myositis
  • Sirolimus
  • Placebo
  • Baltimore, Maryland
    Johns Hopkins University
2021-11-23
Nov 23, 2021
P
Not yet recruiting
  • Lupus Nephritis
  • +2 more
  • Sirolimus
  • (no location specified)
2021-05-13
May 13, 2021
C
Recruiting
  • Kaposiform Hemangioendothelioma
  • Kasabach-Merritt Syndrome
  • Sirolimus
  • Shanghai, Shanghai, China
    Children's Hospital of Fudan University
2021-08-02
Aug 2, 2021
S
Completed
  • Leukemia
  • +3 more
  • Sirolimus
  • +6 more
  • Stanford, California
    Stanford University School of Medicine
2021-09-16
Sep 16, 2021
U
Recruiting
  • Pulmonary Fibrosis
  • +2 more
  • Sirolimus
  • Chicago, Illinois
    University of Chicago
2021-07-19
Jul 19, 2021
N
Completed
  • Age-Related Macular Degeneration
  • Geographic Atrophy
  • Sirolimus
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-06-14
Jun 14, 2021
S
Not yet recruiting
  • Lupus Erythematosus, Systemic
  • Sirolimus
  • Placebo
  • (no location specified)
2021-02-01
Feb 1, 2021
N
Enrolling by invitation
  • Severe Combined Immunodeficiency (SCID)
  • Sirolimus
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
P
Recruiting
  • Retroperitoneal Fibrosis
  • Beijing, Beijing, China
    Peking University International Hospital
2021-03-10
Mar 10, 2021